For the quarter ended September 2024, Amphastar Pharmaceuticals (AMPH) reported revenue of $191.21 million, up 5.9% over the same period last year. EPS came in at $0.96, compared to $1.15 in the year-ago quarter.The reported revenue represents a surprise of -2.51% over the Zacks Consensus Estimate of $196.15 million. With the consensus EPS estimate being $1.01, the EPS surprise was -4.95%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare ...